Progress in stem cell therapy for Alzheimer's disease
Yudong LIU; Shenggang SUN.
International Journal of Biomedical Engineering
; (6): 291-294, 2009.
ArtÃculo en Zh | WPRIM | ID: wpr-392319
Documentos relacionados
Dual enkephalinase inhibitor PL37 as a potential novel treatment of migraine: evidence from a rat model.
Neprilysin gene transfer: A promising therapeutic approach for Alzheimer's disease.
Enhancement of Neprilysin Activity by Natural Polyphenolic Compounds and Their Derivatives in Cultured Neuroglioma Cells.
Anorectic efficacy and safety of the diethylpropion-topiramate combination in rats.
Regulation of Neprilysin Activity and Cognitive Functions in Rats After Prenatal Hypoxia.
Effectiveness of Combinational Treatments for Alzheimer's Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes.
Endoplasmic Reticulum Associated Degradation of Spinocerebellar Ataxia-Related CD10 Cysteine Mutant.
A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: An in silico-based investigation.
Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review.
[Effects of benzo(a)pyrene on expressions of insulin-degrading enzyme and neprilysin in neuroglia cells].